Rhoda Elison Hirsch Selected Research

hemoglobin XL99alpha

1/2002

Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rhoda Elison Hirsch Research Topics

Disease

4	Thalassemia 01/2018 - 07/2011
2	Hemoglobinopathies 10/2017 - 08/2006
2	Anemia 07/2011 - 01/2002
1	Hemolytic Anemia 12/2002
1	Hemoglobin SC Disease (Disease, Hemoglobin SC) 08/2002
1	Sickle Cell Anemia (Hemoglobin S Disease) 06/2002

Drug/Important Bio-Agent (IBA)

6	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2002
2	Hemoglobin EIBA 01/2018 - 01/2016
1	Nitrite Reductases (Nitrite Reductase)IBA 01/2018
1	NitritesIBA 01/2018
1	deoxyhemoglobinIBA 01/2018
1	Free RadicalsIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Membrane LipidsIBA 08/2006
1	Phosphates (Orthophosphate)IBA 12/2002
1	BuffersIBA 12/2002
1	Hemoglobin CIBA 12/2002
1	sickle deoxyhemoglobinIBA 06/2002
1	PolymersIBA 06/2002
1	MyoglobinIBA 01/2002
1	hemoglobin glutamer-200IBA 01/2002
1	hemoglobin XL99alphaIBA 01/2002
1	Oxygen (Dioxygen)IBA 01/2002

Therapy/Procedure

1	Therapeutics 10/2017